National Health Investors, Inc. (NYSE:NHI) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of National Health Investors, Inc. (NYSE:NHI) have been given a consensus recommendation of “Moderate Buy” by the nine ratings firms that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and six have issued a buy recommendation on the company. The average 12 month target price among brokers that have covered the stock in the last year is $82.25.

A number of brokerages recently issued reports on NHI. Weiss Ratings reiterated a “buy (b-)” rating on shares of National Health Investors in a research note on Wednesday, September 9th. BMO Capital Markets lowered their price target on National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a report on Monday, June 15th. Huntington began coverage on National Health Investors in a research note on Thursday, September 10th. They issued an “outperform” rating and a $79.00 target price on the stock. Wells Fargo & Company cut their price objective on National Health Investors from $79.00 to $78.00 and set an “equal weight” rating for the company in a research report on Tuesday, September 1st. Finally, Truist Financial cut their price objective on National Health Investors from $81.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, September 2nd.

National Health Investors Trading Up 0.2%

NYSE NHI opened at $70.47 on Tuesday. The company has a current ratio of 6.78, a quick ratio of 6.78 and a debt-to-equity ratio of 0.81. National Health Investors has a 1-year low of $67.94 and a 1-year high of $91.38. The stock has a 50-day moving average of $74.62 and a 200-day moving average of $77.33. The firm has a market cap of $3.46 billion, a PE ratio of 20.37, a price-to-earnings-growth ratio of 3.75 and a beta of 0.52.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. The firm had revenue of $121.32 million during the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The business’s revenue was up 1.6% on a year-over-year basis. During the same period last year, the company posted $1.22 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, sell-side analysts forecast that National Health Investors will post 4.76 EPS for the current year.

National Health Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be issued a $0.92 dividend. This represents a $3.68 annualized dividend and a dividend yield of 5.2%. The ex-dividend date of this dividend is Wednesday, September 30th. National Health Investors’s dividend payout ratio (DPR) is currently 106.36%.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. BlackRock Inc. acquired a new position in National Health Investors in the 2nd quarter valued at about $665,997,000. California State Teachers Retirement System lifted its holdings in National Health Investors by 7,748.8% in the second quarter. California State Teachers Retirement System now owns 4,077,393 shares of the real estate investment trust’s stock valued at $310,942,000 after acquiring an additional 4,025,444 shares during the last quarter. Principal Financial Group Inc. increased its stake in National Health Investors by 2.0% during the first quarter. Principal Financial Group Inc. now owns 1,700,908 shares of the real estate investment trust’s stock worth $137,537,000 after acquiring an additional 32,902 shares during the last quarter. Bank of New York Mellon Corp purchased a new stake in National Health Investors in the second quarter valued at $122,509,000. Finally, Geode Capital Management LLC lifted its stake in shares of National Health Investors by 1.5% in the 4th quarter. Geode Capital Management LLC now owns 1,262,657 shares of the real estate investment trust’s stock valued at $96,443,000 after purchasing an additional 18,198 shares during the last quarter. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc (NYSE:NHI) is a real estate investment trust that owns and finances healthcare real estate. The company focuses primarily on properties serving older adults and patients requiring specialized care, including independent living, assisted living, memory care, skilled nursing and continuing care retirement communities.

NHI generally leases its properties to healthcare and senior-living operators under long-term agreements, including primarily triple-net leases, under which tenants are typically responsible for property-level operating expenses, maintenance and taxes.